Co-Diagnostics Inc. [CODX] has traded in a range of $0.85 to $30.99 in the last 1 year. As of this writing, the stock is at $14.63, up 2.90%. To check whether the stock’s short-term amount has a thrust, its good to check stock’s recent movement. Over the last week, CODX shares are -4.11% down with the monthly amount drift of 3.72% and seems well in a long time frame.

On 2, October 2020, Co-Diagnostics, Inc. Logix Smart Kit to be Used with Newly Authorized Saline Oral Rinse Collection. According to news published on Yahoo Finance, Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, announced today that Access Genetics, LLC dba OralDNA® Labs, a CLIA-certified customer who uses the Company’s Logix Smart™ COVID-19 kit in their FDA authorized OraRisk® COVID-19 RT-PCR test, recently received an amended Emergency Use Authorization (EUA) allowing testing from a saline oral rinse collection.

Analyst Birdseye View:

The most recent analyst activity for Co-Diagnostics Inc. [NASDAQ:CODX] stock was on May 18, 2020, when it was Reiterated with a Buy rating from H.C. Wainwright, which also raised its 12-month price target on the stock from $20 to $35. On March 09, 2020, H.C. Wainwright Reiterated a Buy rating and boosted its price target on this stock from $4 to $20. On March 03, 2020, Maxim Group Downgrade a Hold rating.

In the past 52 weeks of trading, this stock has oscillated between a low of $0.85 and a peak of $30.99. Right now, the middling Wall Street analyst 12-month amount mark is $33.00. At the most recent market close, shares of Co-Diagnostics Inc. [NASDAQ:CODX] were valued at $14.63.

FUNDAMENTAL ANALYSIS

Co-Diagnostics Inc. [NASDAQ:CODX] most recently reported quarterly sales of 24.04 billion, which represented growth of 38942.90%. This publicly-traded organization’s revenue is $9,347 per employee, while its income is -$269,372 per employee. This company’s Gross Margin is currently 65.40%, its Operating Margin is 30.50%, its Pretax Margin is -2882.00, and its Net Margin is -2882.00. Continuing to look at profitability, this corporation’s Return on Assets, Equity, Whole Principal & invested Principal is sitting at -328.81, -1,826.40, -455.64 and -1,826.40 respectively.

Readers are usually of view to make a close observation to the indicators that support and make resistance before moving to any particular stock. As of now, the company’s stock is sitting at 13.85 points at 1st support level, the second support level is making up to 13.48. But as of 1st resistance point, this stock is sitting at 14.52 and at 14.83 for 2nd resistance point.

Co-Diagnostics Inc. [CODX] reported its earnings at $0.43 per share in the fiscal quarter closing of 6/29/2020. The Analysts for Wall Street were expecting to report its earnings at $0.59/share signifying the difference of -0.16 and -27.10% surprise value. Comparing the previous quarter ending of 3/30/2020, the stated earnings were -$0.05 calling estimates for -$0.05/share with the difference of 0 depicting the surprise of 0.00%.

Important Ratio’s To Watch

Meanwhile, turning our focus to liquidity, the Current Ratio for Co-Diagnostics Inc. [NASDAQ:CODX] is 11.60. Likewise, the Quick ratio is also the same, showing Cash ratio at 2.72. Now if looking for a valuation of this stock’s amount to sales ratio it’s 69.78, it’s amount to book ratio is 8.94 and showing 78.56 of P/E (TTM) ratio.

Insider Stories

The most recent insider trade was by SERBIN RICHARD S, Director, and it was the sale of 25000.0 shares on May 28. Durenard Eugene, the Director, completed a sale of 25000.0 shares on May 26. On May 20, Durenard Eugene, Director, completed a sale of 25000.0 shares.